SWOG treatment protocols and cytogenetics for 849 patients
| SWOG trial . | Disease . | Age (y) . | Total patients registered on study . | Normal . | + 8 . | Others . | Cytogenetically evaluable (%) . |
|---|---|---|---|---|---|---|---|
| S9031 | AML | > 55 | 234 | 78 | 26 | 76 | 180 (77) |
| S9034 | AML | 16-55 | 293 | 91 | 24 | 134 | 249 (85) |
| S9333 | Non M3 AML | > 55 | 334 | 101 | 35 | 126 | 262 (78) |
| S9500 | Non M3 AML | 18-55 | 104 | 34 | 9 | 40 | 83 (80) |
| S9129 | M3 AML | Any | 92 | 3 | 14 | 58 | 75 (82) |
| Total | — | — | 1057 | 307 | 108 | 434 | 849 (80) |
| SWOG trial . | Disease . | Age (y) . | Total patients registered on study . | Normal . | + 8 . | Others . | Cytogenetically evaluable (%) . |
|---|---|---|---|---|---|---|---|
| S9031 | AML | > 55 | 234 | 78 | 26 | 76 | 180 (77) |
| S9034 | AML | 16-55 | 293 | 91 | 24 | 134 | 249 (85) |
| S9333 | Non M3 AML | > 55 | 334 | 101 | 35 | 126 | 262 (78) |
| S9500 | Non M3 AML | 18-55 | 104 | 34 | 9 | 40 | 83 (80) |
| S9129 | M3 AML | Any | 92 | 3 | 14 | 58 | 75 (82) |
| Total | — | — | 1057 | 307 | 108 | 434 | 849 (80) |